PRICE T ROWE ASSOCIATES INC /MD/ - CATABASIS PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of CATABASIS PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2021$151,000
-28.8%
71,800
-2.0%
0.00%
Q1 2021$212,00073,2290.00%
Other shareholders
CATABASIS PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 300,000$2,421,0001.60%
SV Health Investors, LLC 285,765$2,306,0001.55%
Alyeska Investment Group, L.P. 1,125,000$9,079,0000.12%
FEDERATED HERMES, INC. 2,189,400$17,668,0000.04%
OXFORD ASSET MANAGEMENT LLP 139,451$1,125,0000.02%
OPPENHEIMER & CO INC 68,706$554,0000.02%
RMB Capital Management, LLC 60,618$489,0000.01%
Blackstone Inc. 200,819$1,621,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 20,900$169,0000.00%
DIMENSIONAL FUND ADVISORS LP 218,651$1,765,0000.00%
View complete list of CATABASIS PHARMACEUTICALS IN shareholders